Capital Analysts, LLC Tricida, Inc. Transaction History

Capital Analysts, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	BUY	$18.43 - $38.04 $9,215 - $19,020	500 New	500 $11,000
Q4 2019 Feb 12, 2020	SELL	$29.6 - $43.71 $29,600 - $43,710	-1,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$29.87 - $42.22 $29,870 - $42,220	1,000 New	1,000 $30,000
Q2 2019 Aug 13, 2019	SELL	$31.16 - $39.46 $31,160 - $39,460	-1,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$19.96 - $38.62 $19,960 - $38,620	1,000 New	1,000 $38,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.